Ameriprise
KURA icon

Ameriprise’s Kura Oncology KURA Stock Holding History

Ameriprise’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.24M Sell
204,614
-21,546
-10% -$203K ﹤0.01% 3012
2026
Q1 		$1.84M Sell
226,160
-120,516
-35% -$1.04M ﹤0.01% 3001
2025
Q4 		$3.6M Buy
346,676
+19,112
+6% +$201K ﹤0.01% 2672
2025
Q3 		$2.9M Buy
327,564
+314,609
+2,428% +$2.24M ﹤0.01% 2785
2025
Q2 		$74.8K Buy
12,955
+469
+4% +$2.87K ﹤0.01% 3904
2025
Q1 		$82.4K Sell
12,486
-2,440
-16% -$19K ﹤0.01% 3903
2024
Q4 		$130K Buy
+14,926
New +$215K ﹤0.01% 3921
2024
Q3 		– Sell
-182,557
Closed -$3.76M – 3975
2024
Q2 		$3.76M Buy
+182,557
New +$3.75M ﹤0.01% 2510
2021
Q4 		– Sell
-2,391,003
Closed -$44.8M – 4010
2021
Q3 		$44.8M Sell
2,391,003
-90,225
-4% -$1.7M 0.01% 814
2021
Q2 		$51.7M Buy
2,481,228
+7,083
+0.3% +$176K 0.02% 789
2021
Q1 		$69.9M Buy
2,474,145
+1,416,480
+134% +$44.8M 0.02% 627
2020
Q4 		$34.5M Buy
+1,057,665
New +$37.2M 0.01% 912
2018
Q4 		– Sell
-67,260
Closed -$1.18M – 3714
2018
Q3 		$1.18M Buy
67,260
+40,620
+152% +$779K ﹤0.01% 3013
2018
Q2 		$485K Buy
+26,640
New +$451K ﹤0.01% 3259

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Ameriprise's KURA Position: Q2 2026 in Review

Ameriprise reduced its Kura Oncology (KURA) stake by 9.5% in Q2 2026, selling an estimated $203K and leaving 204,614 shares worth $2.24M. The position accounts for ﹤0.01% of the portfolio, ranked #3012.

Ameriprise first reported a position in KURA in Q2 2018 and has held it in 14 quarters since. The position peaked at $69.9M in Q1 2021. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Ameriprise held 204,614 shares of Kura Oncology worth $2.24M as of Q2 2026.
  • Ameriprise sold 21,546 Kura Oncology shares in Q2 2026, an estimated $203K.
  • Kura Oncology made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #3012 holding.
  • Ameriprise first reported a position in Kura Oncology in Q2 2018 and has held it in 14 quarters since.
  • Ameriprise's Kura Oncology position peaked at $69.9M in Q1 2021.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.